Glioblastoma Clinical Trials

Condition  Type  Contact Protocol Study Title
 Glioblastoma  Alliance  Alliance A071102 NEWLY DIAGNOSED GLIOBLASTOMA; MGMT Promoter Hypermethylation; Phase II/III; Veliparib/Placebo in Combination with Adjuvant Temozolomide
   DCVax Glioblastoma Multforme  Randomized study for patient with newly diagnosed grade IV glioblastoma multiforme. A vaccine created from tumor & patients dendritic cells is re-injected over the course of 3 years, with the goal or preventing progression.
 Medulloblastoma    ACNS0332  COG-ACNS0332: Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptic Agent in Other Than Average Risk Medulloblastoma/PNET Patients. Patients > 3 and <22 years at the time of diagnosis